Commission Implementing Regulation (EU) 2026/397 of 23 February 2026 authorising the placing on the market of lacto-N-tetraose produced by a derivative strain of Escherichia coli K-12 MG1655 (ATCC 700926) as a novel food and amending Implementing Regulation (EU) 2017/2470
Article 2
In force · version of Mar 16, 2026
Only the company Inbiose N.V. ( 12 ) is authorised to place on the market within the Union the novel food referred to in Article 1, for a period of 5 years from 16 March 2026, unless a subsequent applicant obtains an authorisation for that novel food without reference to the scientific data protected pursuant to Article 3 or with the agreement of Inbiose N.V.